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Serological Cross-reactivity Between Different 
Chlamydia-like Organisms 
N. Casson*, J.M. Entenza, G. Greub. Center [or 
research on intracellular bacteria, Institute o[ 
M icrobiolog~ Lausanne, Switzerland 
Background: During the Last decade, several new 
species related to Chtamydia have been isolated 
in pure culture and assigned to the Chtamydiates 
order: Parachlarm./dia canthamoebae, Sirnkania 
negevensis, Neochlarm./dia h rtmannellae, Waddlia 
chondrophila, and Protochlarm./dia rnoebophila. 
Several seroLogicaL studies suggested that some of 
these intracettutar bacteria, mainly Parachlarm./dia 
and Simkania, may cause pneumonia nd/or other 
respiratory tract infections. SeroLogicaL tests are 
increasingly used to define the pathogenic rote of 
ChLamydia-Like organisms. 
Objectives: This work intends to define the sero- 
Logical cross-reactivities between these potential 
new agents of pneumonia. 
Methods: Each new chtamydiat species was grown 
using amoebat co-cuLture (a celt culture system 
that uses amoebae as celt background), purified 
on a sucrose barrier and filtered at 1.2Hm. Puri- 
fied bacteria were then injected intravenously to 
6-weeks Batb-C mice. After 4 successive immuniza- 
tions, sera were coLLected and the Level of cross- 
reactivity among these Chtamydia-tike organisms 
was studied by immunofluorescence and western 
blot. 
Results: Sera from mice immunized with the dif- 
ferent Chtamydiates generaLLy exhibited a strong 
reactivity against their autoLogous antigen. Thus, 
titers of ~>1/2048 were obtained foLLowing immu- 
nization with P. acanthamoebae strain HaLL's coccus 
and W. chondrophila. When the sera were tested 
for their reactivity against P. acanthamoebae strain 
BN9, a strong cross-reactivity was detected with 
the sera immunized with the cLoseLy related strain 
P. acanthamoebae strain HaLL's coccus and with 
Protochlarm./dia arnoebophila UWE25, with titers 
of 1/2048 and 1/1024, respectively. A slight cross- 
reactivity was detected with N. hartmannellae 
sera with a titer of 1/128. No cross-reactivity 
with P. acanthamoebae strain BN9 was detected 
with sera elicited with 5. negevensis and W. chon- 
droph ila. 
Conclusion: It is important o determine the Level 
of cross-reactivity among Chtamydia-tike organisms 
to better interpret results from seroepidemiotogi- 
cat studies and to implement efficient seroLogicaL 
diagnostic approaches. Cross-reactivity was mainly 
observed between cLoseLy related species. These 
data should be taken into account for the design 
and for the interpretation of seroLogicaL studies, 
aiming at better understanding the pathogenic po- 
tential of Chtamydia-tike organisms towards hu- 
mans and animals. 
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Chlamydia-like Organisms: A Role as New Agents 
of Pneumonia? 
N. Casson*, J-D. Aubert, E Owojaiye, J. BiLLe, 
G. Greub. Center [or research on intracellular 
bacteria, Institute o[ Microbiology, Lausanne, 
Switzerland 
Background: During the Last years, several obligate 
intraceLLuLar bacteria naturaLLy infecting free-Living 
bacteria have been discovered including Parach- 
lamydia acanthamoebae and Simkania negevensis. 
Based on moLecuLar and seroLogicaL studies, these 
novel species seem to be possible novel agents of 
respiratory tract infection. 
Objectives: This work intended to better define 
the role played by Parachlamydia nd Simkania as 
agents of pneumonia. 
Methods: ALL immunocompetent patients with or 
without pneumonia that undergo bronchoscopy 
were prospectively included. Broncho-aLveoLar 
tavage (BAL) were tested for presence of 
ChLamydia-Like organisms by amoeba[ co-cuLture 
(ceLL culture system using amoebae as ceLL back- 
ground) and by PCR. In addition, Parachlamydia 
and Simkania immunofluorescence was carried out 
on first and convalescent sera. Western-bLot was 
performed to confirm immunofluorescence results. 
Results: As many as 42% of included patients pre- 
sented with pneumonia. No amoeba[ co-cuLture 
was found to be positive. Two samples were found 
positive for a ChLamydiaLes by PCR and sequencing. 
The first sample was taken from a patient, who 
presented a severe community-acquired pneumo- 
nia with cough, sputa, dyspnea, fever, Lung infiL- 
trate, and [eucocytosis. The best blast hit of the 
sequence was Pr. amoebophila. The second posi- 
tive BAL was taken from a patient with persistent 
cough, dyspnea and a Lung infiltrate. The best blast 
hit of this second sequence was P. acanthamoebae 
strain HaLL's coccus. The prevalence of antibody 
reactivity against both Parachlamydia nd Simka- 
nia was not statisticaLLy different between patients 
with and without pneumonia. Two patients ex- 
hibited seroLogicaL evidence of acute Parachlamy- 
dia infection. One of them, who was investigated 
by bronchoscopy for pneumonia, also exhibited a 
positive Simkania serology. Moreover, among the 
12 patients with seroLogicaL evidence of a Simkania 
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acute infection, 3 exhibited a community-acquired 
pneumonia, 3 presented with nosocomia[ pneumo- 
nia, and 2 suffered from bronchitis. 
Conclusions: Using a pan-Ch[amydia[es 16S PCR, 
we identified 2 patients who had parach[amydia[ 
DNA in their respiratory tract secretion. Both pa- 
tients presented signs of severe pneumonia. For 
both Porachlornydio and Simkonio, we found no 
statistical difference in seropreva[ence between 
patients with and without pneumonia. The role of 
Porachlornydio and Sirnkonio as agents of pneumo- 
nia is still unclear and merits further investigations. 
